Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF Trial (Late breaking science)

Citation
Kosiborod MN, Jhund PS, Docherty KF, et al. Circulation. 2020;141:90–9.